THE RARE SIDE EFFECT OF BOTULINUM THERAPY IS A VASOSPASTIC REACTION AT THE INJECTION SITES
- Authors: Sharova A.1, Lysikova V.1
-
Affiliations:
- N.I. Pirogov Russian National Research Medical University
- Issue: Vol 28, No 12 (2017)
- Pages: 60-62
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/117089
- ID: 117089
Cite item
Open Access
Access granted
Abstract
The paper describes a rare clinical case of a vasospastic reaction after injection of botulinum toxin type A (BT-A) into the forehead and glabella, as aesthetically indicated. It analyzes the data available in the literature, which describe similar cases, and discusses the possible mechanisms underlying the action of BT-A on vascular tone.
Full Text
About the authors
A. Sharova
N.I. Pirogov Russian National Research Medical University
Email: aleca@mail.ru
Candidate of Medical Sciences
V. Lysikova
N.I. Pirogov Russian National Research Medical University
References
- https://www.surgery.org/sites/default/files/ASAPS-Stats2016.pdf
- de Almeida H. Jr., Henkin C., Milman L. et al. Localized flushing absence after abobotulinum toxin A cosmetic treatment // Eur. J. Dermatol. - 2013; 23 (5): 714-5.
- Warren D., Woody M., Vickers J. Facial Blanching After Cosmetic Botulinum Toxin Injection: Case Series // Skinmed. - 2016; 14 (3): 239-40.
- Khan T., Herne K., Dayan S. et al. Facial blanching due to neurotoxins: proposed mechanisms // Dermatol. Surg. - 2013; 39 (1 Pt. 1): 24-9.
- Pomprasit M., Chintrakarn C. Treatment of Frey's syndrome with botulinum toxin // J. Med. Assoc. Thai. - 2007; 90 (11): 2397-402.
- Park K., Hyun M., Jeong S. et al. Botulinum toxin for the treatment of refractory erythema and flushing of rosacea // Dermatology. - 2015; 230 (4): 299-301.
- Odo M., Odo L., Farias R. et al. Botulinum toxin for the treatment of menopausal hot flushes: a pilot study // Dermatol. Surg. - 2011; 37 (11): 1579-83.
- Yuraitis M., Jacob C. Botulinum toxin for the treatment of facial flushing // Dermatol. Surg. - 2004; 30 (1): 102-4.
- Eshghi G., Khezrian L., Alirezaei P. Botulinum Toxin A in Treatment of Facial Flushing // Acta Med. Iran. - 2016; 54 (7): 454-7.
- Geddoa E., Matar H., Paes T. The use of botulinum toxin-A in the management of neck and anterior chest wall flushing: pilot study // Int. J. Dermatol. - 2013; 52 (12): 1547-50.
- Manhäes R., Spitz M., Vasconcellos L. Botulinum toxin for treatment of Harlequin syndrome // Parkinsonism Relat. Disord. - 2016; 23: 112-3
- Low D., Hubing K., Del Coso J. et al. Mechanisms of cutaneous vasodilation during the postmenopausal hot flash // Menopause. - 2011; 18 (4): 359-65.
- Kellogg D. Jr., Pergola P., Piest K. et al. Cutaneous active vasodilation in humans is mediated by cholinergic nerve cotransmission // Circ. Res. - 1995; 77: 1222-8.
- Morris J., Jobling P., Gibbins I. Differential inhibition by botulinum neurotoxin A of cotransmitters released from autonomic vasodilator neurons // Am. J. Physiol. Heart Circ. Physiol. - 2001; 281 (5): H2124-32.
- Awan K. The therapeutic usage of botulinum toxin (Botox) in non-cosmetic head and neck conditions - An evidence based review // Saudi Pharm. J. - 2017; 25 (1): 18-24.
- Hubing K., Wingo J., Brothers R. et al. Nitric oxide synthase inhibition attenuates cutaneous vasodilation during postmenopausal hot flash episodes // Menopause. - 2010; 17 (5): 978-82.
- Reame N. Why fixing the furrow does not fix the flash: understanding hot flash biology with botulinumneurotoxin. Menopause. - 2011; 18 (4): 348-9.
- Oh Y., Lee N., Suh D. et al. A split-face study using botulinum toxin type B to decrease facial erythema index // J. Cosmet. Laser Ther. - 2011; 13 (5): 243-8.
Supplementary files
